In 2011, retail value sales of OTC adult mouth care products in Germany are expected to decline by 2% to almost €72 million, the fourth year in a row showing negative development. The reason for the decline is the constantly improved oral hygiene. The high cost of dental treatment, which to an increasing degree is usually not covered by the health insurance system, is a strong incentive for people to maintain good oral hygiene and avoid the high cost of visits to the dentist.
Euromonitor International's Adult Mouth Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Adult Mouth Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Adult Mouth Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
ADULT MOUTH CARE IN GERMANY
Euromonitor International
July 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Adult Mouth Care: Value 2006-2011
Table 2 Sales of Adult Mouth Care: % Value Growth 2006-2011
Table 3 Adult Mouth Care Company Shares by Value 2007-2011
Table 4 Adult Mouth Care Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Adult Mouth Care: Value 2011-2016
Table 6 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016
GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline GmbH & Co KG: Key Facts
Summary 2 GlaxoSmithKline GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 3 GlaxoSmithKline GmbH & Co KG: Production Statistics 2011
Competitive Positioning
Summary 4 GlaxoSmithKline GmbH & Co KG: Competitive Position 2011
Johnson & Johnson GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 5 Johnson & Johnson GmbH: Key Facts
Summary 6 Johnson & Johnson GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Johnson & Johnson GmbH: Competitive Position 2011
Stada Arzneimittel AG in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 8 STADA Arzneimittel AG: Key Facts
Summary 9 STADA Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 STADA Arzneimittel AG: Competitive Position 2011
Executive Summary
Consumer Health Overall Stagnating in Germany in 2011
Market Under Pressure From Healthier Diets and More Exercise
Very Fragmented Market Continues To Be Led by Bayer Vital
Consumer Healthcare Most Often Sold in Health and Beauty Retailers
Small Decline of Consumer Health Expected Over Forecast Period in Germany
Key Trends and Developments
Ongoing Relatively Favourable Economic Conditions in Germany in 2011
Demographic Changes Continue To Influence Consumer Health in Germany
Increasing Shares of Sales Through Internet Retailing in Consumer Health
Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers
Innovation Essential for Premium Brands To Thrive in Consumer Health
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Switches
Summary 11 OTC - Switches 2010-2011
Definitions
Sources
Summary 12 Research Sources
Euromonitor International
July 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Adult Mouth Care: Value 2006-2011
Table 2 Sales of Adult Mouth Care: % Value Growth 2006-2011
Table 3 Adult Mouth Care Company Shares by Value 2007-2011
Table 4 Adult Mouth Care Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Adult Mouth Care: Value 2011-2016
Table 6 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016
GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline GmbH & Co KG: Key Facts
Summary 2 GlaxoSmithKline GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 3 GlaxoSmithKline GmbH & Co KG: Production Statistics 2011
Competitive Positioning
Summary 4 GlaxoSmithKline GmbH & Co KG: Competitive Position 2011
Johnson & Johnson GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 5 Johnson & Johnson GmbH: Key Facts
Summary 6 Johnson & Johnson GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Johnson & Johnson GmbH: Competitive Position 2011
Stada Arzneimittel AG in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 8 STADA Arzneimittel AG: Key Facts
Summary 9 STADA Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 STADA Arzneimittel AG: Competitive Position 2011
Executive Summary
Consumer Health Overall Stagnating in Germany in 2011
Market Under Pressure From Healthier Diets and More Exercise
Very Fragmented Market Continues To Be Led by Bayer Vital
Consumer Healthcare Most Often Sold in Health and Beauty Retailers
Small Decline of Consumer Health Expected Over Forecast Period in Germany
Key Trends and Developments
Ongoing Relatively Favourable Economic Conditions in Germany in 2011
Demographic Changes Continue To Influence Consumer Health in Germany
Increasing Shares of Sales Through Internet Retailing in Consumer Health
Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers
Innovation Essential for Premium Brands To Thrive in Consumer Health
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Switches
Summary 11 OTC - Switches 2010-2011
Definitions
Sources
Summary 12 Research Sources